Journals / Bozok Veterinary Sciences / 2026 / Sayı: 2026

ENVIRONMENTAL CONTAMINATION OF VETERINARY DRUGS: A TRADITIONAL REVIEW

VETERİNER İLAÇLARININ ÇEVRESEL KONTAMİNASYONU: GELENEKSEL DERLEME

Nimet Kılıç(ADNAN MENDERES ÜNİVERSİTESİ, AYDIN SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU)0000-0003-2149-388X
Kerem Uzun(AYDIN ADNAN MENDERES ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ, VETERİNER PR.)0000-0002-4546-4832
Nuh Kılıç(AYDIN ADNAN MENDERES ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ, VETERİNER PR.)0000-0001-8452-161X
Pages
—
Publication Date
2026-06-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review systematically evaluates the literature on drugs used in veterinary medicine and their effects on the environment, and attempts to provide information on the environmental impacts of veterinary drugs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Today, a wide variety of chemical products and drugs are used for treatment in both human and veterinary medicine.
📊
Key Findings & Data:These chemical products and drugs generate significant amounts of residue and waste during their production stages and when used for treatment in pet clinics, livestock breeding facilities, aquaculture facilities, and beekeeping areas.
💡
Conclusion & Impact:This review systematically evaluates the literature on drugs used in veterinary medicine and their effects on the environment, and attempts to provide information on the environmental impacts of veterinary drugs.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:çevre · ilaç · kalıntı

Abstract

Today, a wide variety of chemical products and drugs are used for treatment in both human and veterinary medicine. Antibiotics, antiparasitic drugs, antifungals, hormones, and a wide variety of other veterinary drugs are widely used in the prevention and treatment of diseases in animals, resulting in their direct or indirect entry into the environment. Veterinary drugs, like other drugs, are known to be a group of potential chemical pollutants that retain biological activity even at very low concentrations. These chemical products and drugs generate significant amounts of residue and waste during their production stages and when used for treatment in pet clinics, livestock breeding facilities, aquaculture facilities, and beekeeping areas. If these residues and waste are not disposed of properly, they can become pollutants for the environment. Potential environmental contamination can lead to soil, groundwater, surface water, and air pollution. As a result, these residues and wastes can directly affect humans, animals, and plants through contact, and can also indirectly affect human and animal health from a toxicological perspective when water, plant, and animal products are consumed as food. Therefore, this is considered an important issue that needs to be addressed. This review systematically evaluates the literature on drugs used in veterinary medicine and their effects on the environment, and attempts to provide information on the environmental impacts of veterinary drugs.

Özet

Günümüzde hem beşeri hekimlik hem de veteriner hekimliği alanında tedavi amacıyla çok farklı türde ve sayıda kimyasal ürün ve ilaç kullanılmaktadır. Antibiyotikler, antiparaziter ilaçlar, antifungaller, hormonlar gibi çok çeşitli veteriner ilaçlarının, hayvanlarda hastalıkların önlenmesi ve tedavisinde yaygın olarak kullanımı sonucu, çevreye doğrudan ya da dolaylı olarak giriş yapmaktadır. Veteriner ilaçları diğer ilaçlar gibi çok düşük konsantrasyonlarda bile biyolojik aktiviteye sahip potansiyel kimyasal kirletici grubu olarak bilinmektedir. Bu kimyasal ürün ve ilaçlar üretim aşamaları ile pet hayvanı klinikleri, büyükbaş hayvan üretim tesisleri, su ürünleri üretim tesisleri ve arıcılık yapılan yerlerde tedavi maksadıyla kullanıldıklarında çok fazla miktarda kalıntı ve atık ortaya çıkmakta olup bu kalıntı ve atıklar uygun şekilde bertaraf edilmemeleri halinde çevre için kirletici konumuna geçebilmektedirler. Oluşabilecek çevresel kontaminasyon toprak, yer altı ve yer üstü suları ve hava kirliliğine neden olabilmektedir. Bunun sonucu olarak bu kalıntı ve atıklar insan, hayvan ve bitkileri doğrudan temas yoluyla etkileyebileceği gibi su, bitkisel ve hayvansal ürünlerin gıda olarak tüketilmesi durumunda dolaylı olarak da insan ve hayvan sağlığını toksikolojik yönden etkileyebilmesi sebebiyle üzerinde durulması gereken önemli bir konu olarak görülmektedir. Bu derlemede veteriner hekimliğinde kullanılan ilaçlar ve bunların çevre üzerine etkileri hakkında literatür bilgileri sistematik olarak değerlendirilmiş olup veteriner hekimliği ilaçlarının çevreye olan etkileri hakkında bilgi verilmeye çalışılmıştır.

🔖

Cite This Article

Kılıç, N., Uzun, K., Kılıç, N. (2026). ENVIRONMENTAL CONTAMINATION OF VETERINARY DRUGS: A TRADITIONAL REVIEW. Bozok Veterinary Sciences, Sayı: 2026. https://doi.org/10.58833/bozokvetsci.1908083

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (70)

  1. Kolodziejska M, Maszkowska J, Bialk-Bieliska A, Steudte S, Kumirska J, et al. Aquatic toxicity of four veterinary drugs commonly applied in fish farming and animal husbandry. Chemosphere 2013; 92:1253-1259.
  2. Bottoni P, Caroli S, Caracciolo AB. Pharmaceuticals as priority water contaminants. Toxicological and Environmental Chemistry 2010;92(3):549-565.
  3. Arnold KE, Boxall A, Brown AR, Cuthbert RJ, Gaw S, et al. Assessing the exposure risk and impacts of pharmaceuticals in the environment on individuals and ecosystems. Biology letters 2013;9: 20130492.
  4. Celander MC, Goldstone JV, Denslow ND, Iguchi T, Kille P, et al. Species extrapolation for the 21st century. Environmental Toxicology and Chemistry 2011;30(1):52-63.
  5. Jørgensen SE, Halling-Sørensen B. Drugs in the environment. Chemosphere 2000;40(7):691-699.
  6. Bártíková H, Podlipná R, Skálová L. Veterinary drugs in the environment and their toxicity to plants. Chemosphere 2016; 144:2290-2301.
  7. Bowen PDG. Antiparasitic products. In: Animal Medicines: A User’s Guide: Transport, Storage and Disposal of Animal Medicines. National Office of Animal Health Ltd, Enfield, UK. 1995.
  8. Navrátilová M, Stuchlíková LR, Matoušková P, Ambrož M, Lamka J, et al. Proof of the environmental circulation of veterinary drug albendazole in real farm conditions. Environmental Pollution 2021; 286:117590.
  9. Larsson DJ. Antibiotics in the environment. Upsala journal of medical sciences 2014;119(2):108-112.
  10. Kümmerer K. Antibiotics in the aquatic environment–a review–part Chemosphere 2009;75(4):417-434.
  11. Czaplewski L, Bax R, Clokie M, et al. Alternatives to antibioticsa pipeline portfolio review. The Lancet Infectious Diseases 2016; 16:239–251.
  12. Ioannou F, Burnsteel C, Mackay DK, Gay CG. Regulatory pathways to enable the licencing of alternatives to antibiotics. Biologicals 2018; 53:72-75.
  13. Omonijo FA, Ni L, Gong J, Wang Q, Lahaye L, et al. Essential oils as alternatives to antibiotics in swine production. Animal Nutrition 2018;4(2):126-136.
  14. El Gemayel LJ, Bashour II. Mechanism of antibiotics uptake in plants. In: Hashmi MZ, editor. Antibiotics and antimicrobial resistance genes: emerging contaminants and associated treatment technologies. Cham: Springer; 2020. p. 155-174.
  15. World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: WHO.: 2015.Food and Agriculture Organization. The FAO Action Plan on Antimicrobial Resistance 2016–2020. Rome: FAO.: 2016.
  16. World Organisation for Animal Health. The OIE Strategy on Antimicrobial Resistance and the Prudent Use of Antimicrobials. Paris: OIE (WOAH).: 2016.
  17. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clinical microbiology reviews. 2011:24(4);718-733.
  18. Landers TF, Cohen B, Wittum TE, Larson EL. A review of antibiotic use in food animals: perspective, policy, and potential. Public health reports. 2012:127(1);4-22.
  19. Manyi-Loh C, Mamphweli S, Meyer E, Okoh A. Antibiotic use in agriculture and its consequential resistance in environmental sources: potential public health implications. Molecules. 2018:23(4);795.
  20. Türkiye Cumhuriyeti Tarım ve Orman Bakanlığı. Ulusal Antimikrobiyal Direnç Stratejik Eylem Planı.: 2017.
  21. Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. EDC-2: the endocrine society's second European Food Safety Authority. Risks for human health related to the presence of endocrine disrupting substances in food.:2017.
  22. Kainz K, Bauer MA, Madeo F, Carmona-Gutierrez D. Fungal infections in humans: the silent crisis. Microbial Cell Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. Journal of fungi 2017:3(4);57.
  23. Wroński M, Trawiński J, Skibiński R. Antifungal drugs in the aquatic environment: A review on sources, occurrence, toxicity, health effects, removal strategies and future challenges. Journal of Hazardous Materials 2024:465;133167.
  24. Gonz´alez-Orteg´on E, Blasco J, Le Vay L, Gim´enez L. A multiple stressor approach to study the toxicity and sub-lethal effects of pharmaceutical compounds on the larval development of a marine invertebrate. Journal of Hazardous Materials 2013:263;233–238.
  25. Boxall ABA, Fogg LA, Lindsay AF, Kay P, Blakwell PA, et al. Prioritization of veterinary medicines in the UK environment. Toxicology Letters 2003:142;207–218.
  26. Lange IG, Daxenberger A, Schiffer B, Witters H, Ibarreta D, et al. Sex hormones originating from different livestock production systems: fate and potential disrupting activity in the environment. Analytica chimica acta 2002:473(1-2);27-37.
  27. Zhao F, Ju F, Huang K, Mao Y, Zhang XX, et al. Comprehensive insights into the key components of bacterial assemblages in pharmaceutical wastewater treatment plants. Science of The Total Environment 2019:651;2148-2157.
  28. Caban M, Stepnowski P. How to decrease pharmaceuticals in the environment? A review. Environmental Chemistry Letters 2021:19(4);3115-3138.
  29. Hektoen H, Berge JA, Hormazabal V, Yndestad M. Persistence of antibacterial agents in marine sediments. Aquaculture 1995:133(3-4);175-184.
  30. Samuelsen OB, Lunestad BT, Husevag B, Hølleland T, Ervik A. Residues of oxolinic acid in wild fauna following medication in fish farms. Diseases of Aquatic Organisms 1991:12;111-119.
  31. Bjo¨rklund HV, Bylund G. Comparative pharmacokinetics and bioavailability of oxolinic acid and oxytetracycline in rainbow trout (Oncorhynchus mykiss). Xenobiotica 1991:21;1511–1520.
  32. Hustvedt SO, Salte R, Vassvik V. Absorption, distribution and elimination of oxolinic acid in Atlantic salmon (Salmo salar L.) after various routes of administration. Aquaculture 1991:95(3-4);193-199.
  33. Campbell WC, Fisher MH, Stapley EO, Albers-Schönberg G, Jacob TA. Ivermectin: a potent new antiparasitic agent. Science 1983:221(4613);823-828.
  34. Chiu SHL, Green ML, Baylis FP, Eline D, Rosegay A, et al. Absorption, tissue distribution, and excretion of tritium-labeled ivermectin in cattle, sheep, and rat. Journal of Agricultural and Food Chemistry 1990:38(11);2072-2078.
  35. Donoho AL. Metabolism and Residue Studies with Actaplanin: Symposium on Aspects of Drug Metabolism in Food-Producing Animals. Drug Metabolism Reviews 1987:18(2-3);163-176.
  36. Magnussen JD, Dalidowicz JE, Thomson TD, Donoho AL. Tissue residues and metabolism of avilamycin in swine and rats. Journal of agricultural and food chemistry 1991:39(2);306-310.
  37. Sommer C, Nielsen BO. Larvae of the dung beetle Onthophagus gazella F.(Col., Scarabaeidae) exposed to lethal and sublethal ivermectin concentrations. Journal of Applied Entomology 1992:114(1-5);502-509.
  38. Stout SJ, Wu J, DaCunha AR, King KG, Lee AH. Maduramicin. alpha.: characterization of carbon-14 derived residues in turkey excreta. Journal of Agricultural and Food Chemistry 1991:39(2);386-391.
  39. Halling-Sørensen B, Jensen J, Tjørnelund J, Montforts MHMM. Worst-case estimations of predicted environmental soil concentrations (PEC) of selected veterinary antibiotics and residues used in Danish agriculture. In: Kümmerer K, editor. Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. Berlin, Heidelberg: Springer Berlin Heidelberg; 2001. p. 143-157.
  40. Orive G, Lertxundi U. Mass drug administration: time to consider drug pollution?. The Lancet 2020:395(10230);1112-1113.
  41. Rosenkranz P, Aumeier P, Ziegelmann B. Biology and control of Varroa destructor. Journal of invertebrate pathology. 2010:103;96-119.
  42. Bogdanov S. Contaminants of bee products. Apidologie. 2006:37(1);1-18.
  43. Wallner K. Varroacides and their residues in bee products. Apidologie. 1999:30(2-3);235-248.
  44. Mutinelli F. The spread of pathogens through trade in honey bees and their products (including queen bees and semen): overview and recent developments. Revue Scientifique et Technique-OIE. 2011:30(1);257.
  45. Rademacher E, Harz M. Oxalic acid for the control of varroosis in honey bee colonies–a review. Apidologie. 2006:37(1);98-120.
  46. Holten-Lu ¨tzøft HC, Halling-Sørensen B, Jo¨rgensen SE. Algae toxicity of antibacterial agents applied in Danish fish farming. Archives of Environmental Contamination and Toxicology 1999:36;1–6.
  47. Wollenberger L, Halling-Sørensen B, Kusk KO. Acute and chronic toxicity of veterinary antibiotics to Daphnia magna. Chemosphere 2000:40;723–730.
  48. Willis KJ, Ling N. The toxicity of emamectin benzoate, an aquaculture pesticide, to planktonic marine copepods. Aquaculture 2003:221(1-4);289-297.
  49. Gu J, Guo L, Zhu Y, Qian L, Shi L, et al. Neurodevelopmental toxicity of emamectin benzoate to the early life stage of zebrafish larvae (Danio rerio). International Journal of Molecular Sciences 2023:24(4);3757.
  50. Dos Louros VL, Silva CP, Nadais H, Otero M, Esteves VI, et al. Oxolinic acid in aquaculture waters: Can natural attenuation through photodegradation decrease its concentration?. Science of The Total Environment, 2020:749;141661.
  51. Kwon JW. Environmental impact assessment of veterinary drug on fish aquaculture for food safety. Drug Testing and Analysis 2016:8(5-6);556-564.
  52. Björklund HV, Råbergh CMI, Bylund G. Residues of oxolinic acid and oxytetracycline in fish and sediments from fish farms. Aquaculture 1991:97(1);85-96.
  53. Samuelsen OB, Torsvik V, Ervik A. Long-range changes in oxytetracycline concentration and bacterial resistance towards oxytetracycline in a fish farm sediment after medication. Science of the Total Environment 1992:114;25-36.
  54. Daniel P. Drugs and chemicals in aquafeeds: The problems and solutions. In: The use of veterinary drugs and vaccines in Mediterranean aquaculture (Vol. 86). CIHEAM Zaragoza; 2009.
  55. Delmas JM, Chapel AM, Sanders P. Determination of flumequine and 7-hydroxyflumequine in plasma of sheep by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 1998:712(1-2);263-268.
  56. Davies IM, Gillibrand PA, McHenery JG, Rae GH. Environmental risk of ivermectin to sediment dwelling organisms. Aquaculture 1998:163(1-2);29-46.
  57. Wang D, Han B, Li S, Du X, Cao Y, et al. Assessment of the fate and effect of ivermectin in a simulated aquaculture ecosystem. Aquaculture Research 2020:51(2);535-541.
  58. Li Q, Zhang D, Yin S, Li Y, Gao X, et al. Feasibility of Using Animal Manure and Manure-Based Fertilizer as Soil Amendments: Veterinary Drugs Occurrence and Ecological Risk. Toxics 2025:14(1);32.
  59. Song W, Guo M. Residual veterinary pharmaceuticals in animal manures and their environmental behaviors in soils. In: He Z, Zhang H, editors. Applied manure and nutrient chemistry for sustainable agriculture and environment. Dordrecht: Springer Netherlands; 2014. p. 23-52.
  60. Kemper N. Veterinary antibiotics in the aquatic and terrestrial environment. Ecological indicators 2008:8(1);1-13.
  61. Hignite C, Azarnoff DL. Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicylic acid in sewage water effluent. Life Sciences 1977:20;337–341.
  62. Cardoso O, Porcher JM, Sanchez W. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge. Chemosphere 2014:115;20–
  63. Alder AC, McArdell CS, Golet EM, Ibric S, Molnar E, et al. Occurrence and Fate of Flouroquinolone, Macrolide, and Sulfanamide Antibiotics During Wastewater Treatment and in Ambient Waters in Switzerland. Symposium Series 791, American Chemical Society, Washington, DC.; 2001. p.56–69.
  64. González-Ortegón E, Blasco J, Le Vay L, Giménez L. A multiple stressor approach to study the toxicity and sub-lethal effects of pharmaceutical compounds on the larval development of a marine invertebrate. Journal of hazardous materials 2013:263;233-238.
  65. Shi H, Sun Z, Liu Z, Xue Y. Effects of clotrimazole and amiodarone on early development of amphibian (Xenopus tropicalis). Toxicological & Environmental Chemistry 2012:94(1);128-135.
  66. Gyllenhammar I, Eriksson H, Söderqvist A, Lindberg RH, Fick J, et al. Clotrimazole exposure modulates aromatase activity in gonads and brain during gonadal differentiation in Xenopus tropicalis frogs. Aquatic toxicology 2009:91(2);102-109.
  67. Björklund H, Bondestam J, Bylund G. Residues of oxytetracycline in wild fish and sediments from fish farms. Aquaculture 1990:86(4);359-367.
  68. Watts CD, Crathorne B, Fielding M, Killops SD. Nonvolatile organic compounds in treated waters. Environmental Health Perspectives 1982:46, 87.
  69. Boxall ABA, Kolpin DW, Halling-Sorensen B. Are veterinary medicines causing environmental risk? Environmental Science & Technology 2003:37;286A–294A.
  70. Boxall ABA, Long C. Veterinary medicines and the environment. Environmental Toxicology and Chemistry 2005:24;759–760.